Aliski William Insider Trades

Insider Trading History

Track insider trading activity for Aliski William. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $387k 96,667 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 45,000 shares
$31.20
$4.00
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $207k 51,667 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.36M 45,000 shares
$74.70
$4.00
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Director
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$3.35k 8,500 shares
$0.39
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Director
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.51k 14,000 shares
$0.39
$0.39
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $26.7k 6,667 shares
Last Trade
Jun 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$232k 6,667 shares
$34.80
$4.00
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Director
Holding Value $5.51k 14,000 shares
Last Trade
Nov 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.4k 14,000 shares
$2.17
$0.39
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $1.92M 66,849 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$384k 4,125 shares
$93.20
$28.76
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $24k 6,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.71M 6,000 shares
$285.00
$4.00
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $1.86M 64,704 shares
Last Trade
Feb 23, 2021 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$140k 1,000 shares
$140.22
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $0 0 shares
Last Trade
Feb 19, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.11M 7,500 shares
$148.14
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $1.89M 65,704 shares
Last Trade
Feb 19, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.12M 7,500 shares
$149.01
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $2.11M 73,204 shares
Last Trade
Feb 19, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.11M 7,500 shares
$148.14
$28.76
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Director
Holding Value $4.72k 12,000 shares
Last Trade
Dec 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.6k 12,000 shares
$4.72
$0.39
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $0 0 shares
Last Trade
Aug 21, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$438k 5,000 shares
$87.56
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $1.64M 57,018 shares
Last Trade
Aug 21, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$433k 5,000 shares
$86.57
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $1.78M 62,018 shares
Last Trade
Aug 21, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$438k 5,000 shares
$87.56
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $1.64M 57,018 shares
Last Trade
Jun 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 6,800 shares
$76.58
$28.76
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $13.7k 3,427 shares
Last Trade
Jun 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$893k 3,427 shares
$260.70
$4.00
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $2.02M 70,350 shares
Last Trade
May 18, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.48M 20,000 shares
$74.02
$28.76
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $1.59M 55,424 shares
Last Trade
May 18, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$544k 7,500 shares
$72.59
$28.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up